VVUS : Analysis & Opinions

  1. VIVUS Inks Deal on Spedra - Analyst Blog

    July 11, 2013
    VIVUS announced that it has entered into a license and commercialization in addition to a supply agreement for Spedra with ...
  2. Arena Seeks Canadian Approval for Belviq - Analyst Blog

    June 28, 2013
    Arena Pharma announced the submission of a marketing application for Belviq in Canada.
  3. Arena Falters on Belviq EU Approval - Analyst Blog

    January 23, 2013
    Arena Pharmaceuticals Inc. (ARNA) recently received 'The Day 180 List of Outstanding Issues' from the European Medicines ...
  4. Update on Orexigen's Contrave - Analyst Blog

    January 10, 2013
    Orexigen Therapeutics, Inc. (OREX) recently provided an update on its obesity candidate, Contrave. The company, which had ...
  5. Alexion Pharmaceuticals and Other Nasdaq Stocks Making Big Moves ...

    January 2, 2013
    After this morning's trading, the market is looking good. The Nasdaq is trading up 2.3%; the S&P 500 is up 1.8%; and the ...
  6. Celgene Among Healthcare's Biggest Movers on January 2, 2013

    January 2, 2013
    The market is having a good day so far: the Nasdaq has risen 2.3%; the S&P 500 is up 1.8%; and the Dow has climbed 1.9%. ...
  7. Regeneron Pharmaceuticals and Other Healthcare Stocks Making ...

    December 27, 2012
    It's been a bad day for the market after the morning's trading. The Nasdaq is down 0.7%; the S&P 500 is trading down 0.8%; ...
  8. Healthcare Stocks, Including St Jude Medical, Making Big Moves ...

    November 21, 2012
    After the morning's trading, the Nasdaq has been relatively flat, the S&P 500 has risen 0.1% and the Dow is trading up 0.2%. ...
  9. Express Scripts and Other Big Movers on the Nasdaq on November ...

    November 6, 2012
    The Nasdaq has been relatively flat, the S&P 500 has moved up 0.4% and the Dow has increased 0.6% so far today. Most stocks ...
  10. McKesson Among Healthcare's Biggest Movers on October 25, 2012

    October 25, 2012
    The market is quiet so far today. The Nasdaq has been relatively flat; the S&P 500 is unchanged; and the Dow has moved little. ...
  11. VIVUS and More Big Movers in Healthcare on October 22, 2012

    October 22, 2012
    Currently, the Nasdaq is trading up 0.5%, the S&P 500 is unchanged and the Dow has moved little. The healthcare sector is ...
  12. Vertex Pharmaceuticals and More Big Movers in Healthcare on October ...

    October 12, 2012
    On a bad day for the market, the Nasdaq has declined 0.2%, the S&P 500 has slipped 0.4% and the Dow has fallen 0.2%. The ...
  13. Eli Lilly and Other Healthcare Stocks Making Big Moves on October ...

    October 10, 2012
    The Nasdaq has been relatively flat, the S&P 500 is down 0.2% and the Dow has decreased 0.5% so far today. The healthcare ...
  14. Questcor Pharmaceuticals Among Healthcare's Biggest Movers on ...

    September 21, 2012
    Currently, the Nasdaq has moved little, the S&P 500 is trading down 0.3% and the Dow has remained steady. The healthcare ...
  15. Buy or Sell? Wednesday's Winners: GWRE, OREX

    September 5, 2012
    Among the biggest winners in Wednesday's early trading are Guidewire Software (Nasdaq: GWRE) and Orexigen Therapeutics (Nasdaq: ...
  16. Pharmacyclics and More Big Movers in Healthcare on August 22, ...

    August 22, 2012
    On a bad day for the market, the Nasdaq has slipped 0.2%, the S&P 500 is trading down 0.4% and the Dow is down 0.5%. The ...
  17. Marvell Technology Among the Nasdaq's Biggest Movers on August ...

    August 17, 2012
    The Nasdaq has increased 0.2%, the S&P 500 has remained steady and the Dow has decreased 0.2% this morning. The Nasdaq Composite ...
  18. Valeant Pharmaceuticals Int (USA) and Other Healthcare Stocks ...

    August 15, 2012
    The Nasdaq is trading up 0.2%, the S&P 500 has remained steady and the Dow remains relatively unchanged so far today. The ...
  19. Loss at Vivus Wider-Than-Expected - Analyst Blog

    August 10, 2012
    Vivus Inc.'s (VVUS) second quarter 2012 loss of 24 cents per share was wider than the Zacks Consensus loss Estimate of 23 ...
  20. Big Movers on the Healthcare Sector Today, Including VRX

    August 7, 2012
    The market is having a good day so far: the Nasdaq has climbed 0.8%; the S&P 500 is up 0.7%; and the Dow has risen 0.6%. ...
  21. Biggest Healthcare Sector Movers for July 24, 2012, Including ...

    July 24, 2012
    On a bad day for the market, the Nasdaq has decreased 0.2%, the S&P 500 has declined 0.5% and the Dow is down 0.6%. The healthcare ...
  22. Healthcare Stocks Making Big Moves on July 19, 2012

    July 19, 2012
    It's been a good morning for the market. The Nasdaq is up 1.1%; the S&P 500 has climbed 0.3%; and the Dow has moved up 0.3%. ...
  23. Arena Pharmaceuticals – One Huge Step Forward, But Many More ...

    June 28, 2012
    ARNA shareholders got some major validation on June 27, 2012, when the company announced that the FDA had formally approved ...
  24. Control May Be Herbalife's Real Long-Term Problem

    June 4, 2012
    Herbalife's model may not be as precarious as feared, but there are some weaknesses and the stock may only see 10% compound ...
  25. Notable Performers Since The Turn Of The Year

    March 20, 2012
    While lesser-known stocks have put up astronomical performances since the turn of the year, many bigger name companies have ...
  26. Nutrisystem Still Searching For Sustainability

    March 12, 2012
    Nutrisystem's membership weakness is a worrisome sign.
  27. Wall Street Isn't Buying The Medifast Story

    March 5, 2012
    Medifast gets a lot of doubt on the Street.
  28. More Yo-Yo'ing At Weight Watchers

    November 11, 2011
    Weight Watchers often seems more popular with investors than customers.
  29. Fattening Up A Portfolio While Slimming Down

    June 1, 2011
    With the numbers of overweight and obese people growing globally, investors may want to consider stocks on the front lines ...
  30. Arena's New Data Doesn't Change Obesity Pill Outlook

    May 30, 2011
    Arena's new data isn't new and doesn't address the company's biggest issues.
  31. Can NutriSystem Find A Healthy Size?

    February 28, 2011
    NutriSystem got crushed on bad earnings guidance, but there could be more value here than people realize.
  32. December's Healthcare Winners and Losers

    January 5, 2011
    Check out December's best and worst Healthcare Stocks.
  33. FDA's Bizarro World - Orexigen Gets Panel Approval!

    December 8, 2010
    In a surprise decision, an FDA panel votes to approve Contrave, Orexigen's new obesity drug.
  34. FDA Locked And Loaded For MELA Sciences

    November 16, 2010
    A harsh FDA review sends MELA down sharply before a pivotal panel meeting.
  35. FDA To Obesity Drugs: Drop Dead

    September 20, 2010
    An FDA panel knocks down yet another would-be obesity drug.
  36. Arena's Big Day Looms Large

    September 15, 2010
    The market seems to be expecting failure for Arena's obesity drug.
  37. There Is Life After Death, At Least In Biotech

    June 22, 2010
    Clinical failure is not the end of the story for all biotechs. How do some survive while others disappear?
  38. Can Investors Fatten Up On Weight Loss?

    June 22, 2010
    Obesity is described as a multi-billion dollar crisis in North America, but how can investors profit from the solutions?
Investing News
  1. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  2. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  3. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  4. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  5. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
  6. Can Paying Off Your Mortgage Early Hurt Your Net Worth?

    Saving your money and making double or even triple payments on a mortgage may sound productive, ...
Trading Center